We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Unilever Plc | LSE:ULVR | London | Ordinary Share | GB00B10RZP78 | ORD 3 1/9P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
219.00 | 5.67% | 4,082.00 | 4,071.00 | 4,073.00 | 4,097.50 | 4,001.00 | 4,047.00 | 11,134,388 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Perfume,cosmetic,toilet Prep | 59.6B | 6.49B | 2.5958 | 15.68 | 101.74B |
Date | Subject | Author | Discuss |
---|---|---|---|
18/1/2022 15:45 | They'd have a job to reject a bid of anything over £46 at the moment. | philanderer | |
18/1/2022 15:43 | The irony is the lower this goes the better the result will be ultimately | spoole5 | |
18/1/2022 15:40 | That 3 year graph is a disgrace - new leadership needed. | pander45 | |
18/1/2022 15:34 | Thought they might. The patient is bleeding heavily. | pander45 | |
18/1/2022 15:34 | Americans have joined the party | nick100 | |
18/1/2022 15:26 | UL price was lower though. Could test that in NY. | patientcapital | |
18/1/2022 15:24 | I did not see this coming albeit GSK hired an ex ULVR to advise on consumer unit spinoff... (the drastic Lewis ext Tesco CEO... I think when they named it I even gave a short thought of this being in the cards as a risk but discarded the hypothesis as weird) | acsatix | |
18/1/2022 15:24 | I did not see this coming albeit GSK hired an ex ULVR to advise on consumer unit spinoff... (the drastic Lewis ext Tesco CEO... I think when they named it I even gave a short thought of this being in the cards as a risk but discarded the hypothesis as weird) | acsatix | |
18/1/2022 15:21 | this was supposed to be my safe holding to balance the more risky tobacco shares :) | acsatix | |
18/1/2022 15:19 | Unilever risks becoming a takeover target as it pursues GSK's consumer healthcare arm Sky's Ian King says the maker of Marmite could find itself the subject of unwanted bid interest as shareholders deliver a rebuke over its strategy. | philanderer | |
18/1/2022 15:15 | so could be lucky GSK did lol. As fund holders won't go for a higher bid. | onehanded | |
18/1/2022 15:13 | cramer on cnbc said GSK were insane to reject such a fully priced bid. | careful | |
18/1/2022 15:12 | Down another 3%. That's 10 billion pounds gone in 2 days. | kev0856153 | |
18/1/2022 15:11 | Margins and ROE still in the 20s here, more important than PE | spoole5 | |
18/1/2022 15:09 | PE means less and less as an indicator. I assume you are monitoring POLY closely. Case in point. | pander45 | |
18/1/2022 15:00 | Undervalued I don't think so high p.e for a ex growth company, analysts worried what they have to pay GSK another 5 billion to 10 billion on what they have offered to get the company. | montyhedge | |
18/1/2022 14:56 | Where is the company statement? They are casually observing the company be seriously devalued. | pander45 | |
18/1/2022 14:50 | Wonder how much lower these clowns will let this drop before they throw in the towel. | spoole5 | |
18/1/2022 14:40 | Yes, Jope and the Board have shot themselves in the foot here. They've left themselves wide open for a takeout. | philanderer | |
18/1/2022 14:16 | subzero chance careful. subzero. and the lower the share price goes the higher the debt burden will be, which is already 4 times ebitda and thats too high. | roguetraderuk | |
18/1/2022 14:06 | Will they get shareholder approval? All of those passive investors with Blackrock ETFs. I wonder if Larry Fink has made up his mind yet. The big boys have their own agenda. | careful | |
18/1/2022 13:35 | More likely a bid for the company now. Someone could really extract value from either a breakup or improve by updating the products. FT online saying a few private equities must be looking as breakup value equivalent to around £54 - £58 share price | onehanded | |
18/1/2022 13:33 | ULVR view on sustainability doesn't apply to the share price :) I could buy a car with this weeks losses :) | marksp2011 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions